Ramiro Gilardino

Policy & Thought Pieces

Policy Brief

Policy briefs are intended for audiences who need clear, actionable insight without unnecessary complexity.

Focused, concise briefs designed to support evidence-informed decision-making in health policy and access strategy. These pieces may address specific policy questions, emerging access challenges, HTA reforms, reimbursement considerations, or practical recommendations for improving the connection between evidence, value, and policy.

  1. Radu, P., et al. (2024). How have HTA agencies evolved their methods over time? OHE Contract Research.
  2. Cossio, C. M., & Gilardino, R. E. (2023). Leveraging electronic health records and artificial intelligence for automated health outcome analysis. Value & Outcomes Spotlight, 9(4), 25–27. ISSN: 2375-866X.
  3. Gilardino, R. (2022). Real world characteristics and outcomes of COVID-19 patients admitted to Argentinean ICUs. Decide-Health Decision Hub. World Health Organization.

White Paper

These pieces provide deeper analysis than short briefs and may include background context, policy landscape assessment, strategic implications, and recommendations for future action.

Longer-form strategic papers exploring complex topics in health economics, innovation access, value assessment, and health system transformation. White papers may examine how policy frameworks are evolving, how evidence requirements are changing.

 

Editorial

Perspective-led articles on emerging issues in health policy, HTA reform, reimbursement, access, and global health strategy. Editorials provide timely reflections on developments affecting the healthcare landscape, including shifts in evidence standards, policy expectations, payer priorities, and the broader public conversation around innovation and value.

These pieces are designed to contribute to the policy dialogue by offering a clear point of view, connecting evidence with real-world implications, and highlighting issues that deserve further discussion.

Opinion

Commentary on current debates in health equity, patient access, innovation, and the translation of evidence into policy action. Opinion pieces may focus on the practical tensions between affordability and innovation, the need for more inclusive value assessment, or the importance of aligning scientific evidence with policy and societal priorities.

These articles are intended to be accessible, reflective, and thought-provoking. They offer a space to discuss where health policy is heading, what challenges remain unresolved.

Conference Presentations

Conference Presentations

  1. Gilardino, R. (2025, May). Leveraging Automated Tools for Literature Reviews in Health Economics and Outcomes Research: Opportunities, Challenges, and Best Practices. Presented at ISPOR 2025, Montreal, Canada.
  2. Gilardino, R. (2024, November). From methods to implementation: Real-world and regulatory applications of patient experience data through patient experience mapping & patient involvement. Presented at ISPOR Europe 2024, Barcelona, Spain.
  3. Gilardino, R. (2024, November). Role of real-world evidence and artificial intelligence in accelerated approvals in oncology: Current status and next steps. Presented at ISPOR Europe 2024, Barcelona, Spain.
  4. Gilardino, R. (2024, November). Can generative AI aid readiness for Joint Clinical Assessment (JCA)? Presented at ISPOR Europe 2024, Barcelona, Spain.
  5. Gilardino, R. (2024, June 27). 20 years of the Global Policy Forum: Providing value to HTAi members and the wider HTA community. Presented at HTAi 2024 Annual Meeting, Seville, Spain.
  6. Ciani, O., & Gilardino, R. E. (2023, November). Healthcare system benefits of improving patient access to early-stage cancer treatments in Europe. Presented at ISPOR Europe, Copenhagen, Denmark.
  7. Gilardino, R. (2023, June 27). Equity in health technology assessment: Approaches to incorporate equity into healthcare decision making. [Lecture]. HTAi 2023 Annual Meeting, Adelaide, Australia.
  8. Gilardino, R. (2022, November 7). Are open-source models really for health technology assessment and health policy? [Lecture]. ISPOR Europe, Vienna, Austria.
  9. Gilardino, R. (2022, June 27). Would novel elements of value contribute to equitable access to medical technologies? [Lecture]. HTAi 2022 Annual Meeting, Utrecht, Netherlands.
  10. Gilardino, R. (2022). Utilizing RWE and HEOR throughout the product lifecycle: From product positioning to market access and reimbursement. [Lecture]. ISPOR 2022, Washington, D.C., USA.
  11. Gilardino, R. (2020, August 26). Global experiences with the use of HTA for health benefit packages development. [Webinar]. ISPOR Global Groups. Link
  12. Gilardino, R. (2020, August 10). The usage of real-world evidence (RWE): Monitoring and managing health technologies in Latin America – Where we are and where we are heading. [Webinar]. ISPOR. Link
  13. Gilardino, R. (2019, November). Use of multi-criteria decision analysis to support decision making and HTA: Latin America experience. [Lecture]. ISPOR Europe, Copenhagen, Denmark.
  14. Gilardino, R. (2019, October). Role of HTA organizations. [Forum presentation]. III International Clinical Engineering and Health Technology Management Congress, Rome, Italy.
  15. Gilardino, R. (2019, September). Role of RWE in decision making in Latin America. [Lecture]. ISPOR Latin America, Bogota, Colombia.
  16. Gilardino, R. (2018, May). Value assessment in Latin America: How far we are – A discussion forum. [Lecture]. ISPOR, Baltimore, MD, USA.
  17. Gilardino, R. E. (2019, August). New methods on value assessment. Presented at the First Oncology Health Economics Summit, Buenos Aires, Argentina.
  18. Gilardino, R. E. (2018, August). Stakeholder involvement in health technology assessment. Presented at the 5th ISPOR Colombian Chapter Congress, Bogota, Colombia.
  19. Gilardino, R. E. (2018, March). Regulatory landscape of medical devices. Presented at the 5th ISPOR Mexican Chapter Summit, Mexico City, Mexico.
  20. Gilardino, R. E. (2017, December). How to assess the performance of medical devices. Presented at the I Medical Devices Forum, ISalud University, Buenos Aires, Argentina.
  21. Gilardino, R. E. (2017, November). Real world evidence to support decision making in emerging countries. Presented at the Cuenta de Alto Costo, Colombian High Cost Fund 10th Year Event, Bogota, Colombia.
  22. Gilardino, R. E. (2017, November). Stakeholder involvement in decision-making process: A discussion forum. Presented at the 20th ISPOR European Congress, Glasgow, UK.
  23. Gilardino, R. E. (2017, July). Stakeholder involvement in health technology assessment. Presented at the VII ISALUD Seminar, Buenos Aires, Argentina.
  24. Gilardino, R. E. (2017, May). Health technology assessment and equity: A discussion forum. Presented at the 22nd ISPOR International Meeting, Boston, USA.
  25. Gilardino, R. E. (2017, March). Economic evaluations in medical devices. Presented at the 4th ISPOR Mexican Chapter Summit, Mexico City, Mexico.
  26. Gilardino, R. E. (2016, October). Economic impact of quality improvement. Presented at the Argentinean Sterilization Club Meeting, Buenos Aires, Argentina.
  27. Gilardino, R. E. (2015, October). Timing for health technology assessment. Presented at the Health Information Systems Summit, Universidad ISALUD, Buenos Aires, Argentina.
  28. Gilardino, R. E. (2015, September). Understanding gaps for technology adoption in three Latin American countries. Presented at the ISPOR 5th Latin American Conference, Santiago, Chile.
  29. Gilardino, R. E. (2015, May). Is bariatric surgery cost-effective? Presented at the International Congress of Bariatric & Metabolic Surgery, Mendoza, Argentina.
  30. Gilardino, R. E. (2015, April). Process improvement as part of quality-of-care cycle. Presented at the Argentinean Health Auditors Meeting, Buenos Aires, Argentina.
  31. Gilardino, R. E. (2014, August). Health technology assessment in medical devices: Role in the decision-making process. Presented at the 3rd Congress of Auditors and Health Managers, SADAM, Buenos Aires, Argentina.

 

Policy briefs, white papers, editorials, and opinion pieces will be added here as they become available.